JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Vanguard Total Bond Market
BND
|
+$1.96B |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.61B |
| 4 |
UnitedHealth
UNH
|
+$1.1B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.25B |
| 2 |
Centene
CNC
|
+$827M |
| 3 |
Amazon
AMZN
|
+$791M |
| 4 |
Texas Instruments
TXN
|
+$716M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$569M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.52% |
| 2 | Technology | 14.62% |
| 3 | Healthcare | 12.48% |
| 4 | Financials | 10.51% |
| 5 | Consumer Discretionary | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Regeneron Pharmaceuticals
REGN
$76.1B
| $3.93B | 0.56% |
5,705,869
+27,437
| +0.5% | +$17.3M |
2013 Q2
37 quarters
|
|
27
Bank of America
BAC
$375B
| $3.89B | 0.56% |
128,722,528
-4,765,827
| -4% | -$159M |
2013 Q2
37 quarters
|
|
28
NXP Semiconductors
NXPI
$58.3B
| $3.81B | 0.55% |
25,846,826
+2,261,258
| +10% | +$379M |
2013 Q3
36 quarters
|
|
|
29
iShares 7-10 Year Treasury Bond ETF
IEF
$41.6B
| $3.8B | 0.55% |
39,638,610
+10,620,545
| +37% | +$1.08B |
2013 Q2
37 quarters
|
|
30
PUT
iShares S&P 100 ETF
OEF
$20.7B
| $3.76B | 0.54% |
42,365,200
+1,489,900
| +4% | +$270M |
2013 Q2
37 quarters
|
|
31
JPMorgan International Research Enhanced Equity ETF
JIRE
$10.8B
| $3.75B | 0.54% |
86,038,014
+131,252
| +0.2% | +$6.37M |
2022 Q2
1 quarter
|
|
32
Morgan Stanley
MS
$294B
| $3.45B | 0.5% |
43,722,452
+1,233,144
| +3% | +$104M |
2013 Q2
37 quarters
|
|
33
Wells Fargo
WFC
$248B
| $3.42B | 0.49% |
85,097,385
-1,532,352
| -2% | -$65.8M |
2013 Q2
37 quarters
|
|
34
United Parcel Service
UPS
$80.1B
| $3.34B | 0.48% |
20,662,111
+388,759
| +2% | +$73.6M |
2013 Q2
37 quarters
|
|
|
35
Texas Instruments
TXN
$263B
| $3.32B | 0.48% |
21,428,551
-4,266,852
| -17% | -$716M |
2013 Q2
37 quarters
|
|
36
Eaton
ETN
$165B
| $3.24B | 0.47% |
24,317,958
-1,082,408
| -4% | -$151M |
2013 Q2
37 quarters
|
|
37
Progressive
PGR
$127B
| $3.19B | 0.46% |
27,427,991
+551,975
| +2% | +$66.5M |
2013 Q2
37 quarters
|
|
38
iShares Core S&P 500 ETF
IVV
$893B
| $3.15B | 0.45% |
8,790,675
+28,525
| +0.3% | +$11.4M |
2013 Q2
37 quarters
|
|
39
Meta Platforms (Facebook)
META
$1.84T
| $3.13B | 0.45% |
23,098,945
+2,234,443
| +11% | +$362M |
2013 Q2
37 quarters
|
|
40
Prologis
PLD
$123B
| $3.11B | 0.45% |
30,632,970
+887,382
| +3% | +$110M |
2013 Q2
37 quarters
|
|
41
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.49B
| $3.09B | 0.44% |
73,119,557
-2,653,968
| -4% | -$126M |
2018 Q3
16 quarters
|
|
42
Lowe's Companies
LOW
$106B
| $3.07B | 0.44% |
16,357,262
-701,775
| -4% | -$137M |
2013 Q2
37 quarters
|
|
43
Analog Devices
ADI
$197B
| $2.96B | 0.43% |
21,244,776
-3,204,298
| -13% | -$507M |
2013 Q2
37 quarters
|
|
44
Norfolk Southern
NSC
$71.2B
| $2.95B | 0.42% |
14,072,552
+422,007
| +3% | +$101M |
2013 Q2
37 quarters
|
|
45
Vanguard S&P 500 ETF
VOO
$1.06T
| $2.92B | 0.42% |
8,880,279
+204,986
| +2% | +$74.9M |
2013 Q2
37 quarters
|
|
46
Procter & Gamble
PG
$350B
| $2.85B | 0.41% |
22,545,243
+220,175
| +1% | +$31.3M |
2013 Q2
37 quarters
|
|
47
RTX Corp
RTX
$248B
| $2.82B | 0.41% |
34,498,569
+1,363,247
| +4% | +$123M |
2013 Q2
37 quarters
|
|
48
Thermo Fisher Scientific
TMO
$241B
| $2.81B | 0.4% |
5,536,388
+397,995
| +8% | +$223M |
2013 Q2
37 quarters
|
|
|
49
CALL
Invesco QQQ Trust
QQQ
$504B
| $2.79B | 0.4% |
10,457,600
-40,400
| -0.4% | -$12.2M |
2013 Q2
37 quarters
|
|
50
Trane Technologies
TT
$103B
| $2.76B | 0.4% |
19,051,191
-1,112,324
| -6% | -$166M |
2013 Q2
37 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2022 Portfolio in Review
As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q3 2022 filing shows 556 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
- JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
- JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
- JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
- JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
- JP Morgan Chase opened 556 new positions and closed 516 in Q3 2022.
- JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.